| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.25B | 41.75B | 37.11B | 35.40B | 33.21B | 25.94B |
| Gross Profit | 9.48B | 11.51B | 9.60B | 9.68B | 9.38B | 6.17B |
| EBITDA | 19.92B | 22.46B | 21.53B | 21.18B | 19.61B | 14.59B |
| Net Income | 2.98B | 3.37B | 3.51B | 4.09B | 3.13B | 1.79B |
Balance Sheet | ||||||
| Total Assets | 85.75B | 100.57B | 75.36B | 69.44B | 72.26B | 62.96B |
| Cash, Cash Equivalents and Short-Term Investments | 14.66B | 14.37B | 11.69B | 11.80B | 15.69B | 11.22B |
| Total Debt | 18.47B | 29.05B | 13.77B | 14.13B | 20.99B | 19.49B |
| Total Liabilities | 30.12B | 40.64B | 21.43B | 20.43B | 30.06B | 26.40B |
| Stockholders Equity | 38.33B | 40.48B | 37.40B | 34.12B | 29.58B | 26.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.64B | 2.71B | 4.26B | 3.93B | 1.56B |
| Operating Cash Flow | 0.00 | 20.14B | 17.47B | 18.33B | 17.03B | 11.42B |
| Investing Cash Flow | 0.00 | -28.68B | -14.61B | -14.66B | -12.19B | -9.65B |
| Financing Cash Flow | 0.00 | 11.84B | -3.56B | -9.62B | -382.90M | -2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $16.50T | 45.29 | 47.37% | 0.25% | 63.36% | 149.43% | |
77 Outperform | ¥591.77B | 24.84 | 12.66% | 2.28% | 9.53% | -11.17% | |
71 Outperform | ¥193.50B | 51.88 | 10.10% | 1.00% | -12.50% | -26.08% | |
71 Outperform | ¥413.68B | 13.71 | ― | 1.02% | 29.60% | 24.39% | |
65 Neutral | ¥79.78B | 17.02 | ― | 1.85% | 3.60% | -17.45% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥117.14B | 43.14 | ― | 2.45% | 4.60% | -21.64% |